Bio-Techne Corp (TECH)
Pretax margin
Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 185,690 | 232,345 | 251,457 | 284,499 | 338,478 | 328,823 | 317,994 | 345,858 | 310,338 | 239,106 | 215,473 | 177,678 | 149,000 | 203,098 | 204,185 | 298,013 | 276,480 | 237,738 | 240,794 | 112,235 |
Revenue (ttm) | US$ in thousands | 1,159,360 | 1,137,352 | 1,130,708 | 1,131,664 | 1,137,169 | 1,125,274 | 1,120,378 | 1,117,527 | 1,094,290 | 1,064,304 | 1,017,313 | 971,607 | 917,080 | 837,177 | 786,479 | 745,873 | 724,111 | 739,941 | 729,495 | 718,184 |
Pretax margin | 16.02% | 20.43% | 22.24% | 25.14% | 29.76% | 29.22% | 28.38% | 30.95% | 28.36% | 22.47% | 21.18% | 18.29% | 16.25% | 24.26% | 25.96% | 39.95% | 38.18% | 32.13% | 33.01% | 15.63% |
June 30, 2024 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $185,690K ÷ $1,159,360K
= 16.02%
The pretax margin of Bio-Techne Corp has shown fluctuations over the past several quarters. The pretax margin represents the percentage of each dollar of revenue that the company retains as profit before paying taxes.
In the most recent quarter, ending June 30, 2024, the pretax margin stood at 16.02%, showing a decrease from the previous quarter's level of 20.43% ending March 31, 2024. This declining trend indicates that the company's profitability before taxes has weakened in the latest period.
Looking back over the past few years, the pretax margin has displayed variability, reaching a peak of 39.95% in the quarter ending December 31, 2020, and a low of 15.63% in the quarter ending September 30, 2019. The company experienced a significant improvement in profitability during the latter half of 2020, but this performance was not sustained over the following quarters.
Overall, Bio-Techne Corp's pretax margin has historically fluctuated, reflecting changes in its operational efficiency, cost management, pricing strategies, and overall economic conditions. It is important for stakeholders to closely monitor these fluctuations and understand the underlying factors influencing the company's profitability.
Peer comparison
Jun 30, 2024